Benjamin C. Carter
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
24
Citations
962
Est. group size
~7
Recurring co-author estimate
Active years
10
Publishing since 2016
Benjamin C. Carter's research focuses on chromatin biology and gene regulation, studying how proteins that package and organize DNA (such as chromatin remodeling complexes like BRD9, PBRM1, and BAF/mSWI-SNF) control processes including cancer progression, cellular stress responses, and early embryonic gene activation. The work spans molecular techniques for mapping histone modifications (chemical marks on DNA-packaging proteins) at low cell numbers, and applications ranging from prostate cancer and kidney disease to plant development and HIV latency.
Publication output has been variable over the last decade, with a notable spike in 2023 followed by lower output in 2024-2025, rather than a steady or clearly growing trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Super RNA Pol II domains enhance minor ZGA through 3D interaction to ensure the integrity of major transcriptional waves in late-ZGA mammals
Cell Genomics · 2025
- ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease
Kidney International · 2024
- Signaling mechanisms in renal compensatory hypertrophy revealed by multi-omics
Nature Communications · 2023
- Data from BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
2023
- Supplementary Data from BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
2023
- Supplementary Tables 1-4 from BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
2023
- Supplementary Tables 1-4 from BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
2023
- Supplementary Data from BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
2023
- Data from BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
2023
- Antibody-guided Chromatin Tagmentation for Two or More Factors (ACT2-seq)
Research Square · 2021
- The epigenetic basis of cellular heterogeneity
Nature Reviews Genetics · 2020
- BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression
Cancer Research · 2020
- Author Correction: Mapping histone modifications in low cell number and single cells using antibody-guided chromatin tagmentation (ACT-seq)
Nature Communications · 2020
- Mapping histone modifications in low cell number and single cells using antibody-guided chromatin tagmentation (ACT-seq)
Nature Communications · 2019
- PBRM1 Regulates Stress Response in Epithelial Cells
iScience · 2019
- Nature Communications×3
- Nature Reviews Genetics×1
- The Plant Cell×1
- Cancer Research×1
- Seminars in Cell and Developmental Biology×1
- Surbhi Sood
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Alisha Dhiman
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Guanming Jiao
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Sandra Torregrosa‐Allen
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Bennet D. Elzey
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile